Debate: Limited state Hodgkin lymphoma patient who remains PET+ at the end of chemotherapy - SCT-based therapy

Debate: Limited state Hodgkin lymphoma patient who remains PET+ at the end of chemotherapy - SCT-based therapy

User Photo
HMP CME

3 years
306 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
In this presentation from Lymphoma & Myeloma 2016, Dr. Koen van Besien argues for stem cell transplant-based therapy in the treatment of a limited stage Hodgkin lymphoma patient who remains PET positive at the end of chemotherapy.

Click to Earn CME Credit: http://bit.ly/2mFKBrY

© 2016 Imedex, LLC.
Up Next Autoplay
>